Simultaneous HPTLC estimation of amlodipine besylate and losartan potassium in tablet dosage form

Indian Drugs

Volumn 41, Issue 1, 2004, Pages 32-35

  Mahadik, K R ^a   Aggrawal, H ^a   Kaul, N ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Amlodipine besylate; HPTLC; Losartan potassium

Indexed keywords

EID: 33744785453     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bhudavari S. Eds., In; The Merck Index, 11th Edn., Merck and Co., Inc., NJ, 1993, 86, 954.
2. Singh S, Jain. R, Indian Drugs, 34(11), 1997, 678-679.
3. Suresh B, Sowmya S, Indian Drugs, 35(5), 1998, 296-297.
4. Ghadge. A. J, Sane. R. T., Indian Drugs, 30(10), 1993, 501-505.
5. Zarapkar S. S, Kolte S. S, Indian Drugs, 34(6), 1997, 350-353.
6. Argekar A. P., Powar S. G, J. Pharm. Biomed. Anal, 2000, 1137-42.
7. Shetkar B. M., Lande N. R, Indian J. of Pharm Sci, 2001, 66-69.
8. Vikram K., Ravi T. K., Indian J. of Pharm. Sci, 2001, 165-166.
9. Farthing D., Sica D., J. Chromatogr. B. Biomed. Sci. Appl, 1997, 374-378.
10. Yeung P. K., Pollak P. T., International. J. of Pharm, 2000, 204(1-2), 17-22.
11. Brooks M. A., Gilbert R.E., J. Pharm. Biomed. Anal, 1998, 671-677.
12. ICH Guidelines Q2B, Validation of analytical procedure: methodology, March (1996), Geneva, Switzerland.